~Leading French Retailer Launches Fruit Yogurts and Yogurt Drinks Containing Reducol(tm)~
Vancouver, Canada Forbes Medi-Tech Inc. (TSX:FMI and NASDAQ:FMTI) today announced that Auchan of France has launched a range of fruit yogurts and yogurt drink products featuring Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm). The Auchan dairy products will be marketed under the 'Auchan' private label brand.
"With over 121 Hypermarkets and 116 Auchan Stores, this adds a substantial partner to our retailer base and broadens the Reducol(tm) brandname in France," said Jeff Motley, Vice President, Marketing & Sales of Forbes Medi-Tech Inc.
Reducol(tm) is a unique ingredient containing plant sterols and stanols, commonly known as phytosterols, or "Sterols". The combination of a prudent diet and consumption of products containing the recommended amount of Reducol(tm) may help consumers lower their cholesterol by up to 24%. Additional information on Reducol(tm) can be found at www.reducol.com
Auchan has become one of the most important distribution groups in the world. Since opening its first store in Roubaix in 1961, Auchan has shown consistent development: it is now established in 11 countries and has some 155,000 employees throughout the world. Auchan develops two retail formats: hypermarkets (354 in the world) and supermarkets (645).
It is also supported by real estate activity (shopping center management), with Immochan, and banking (payment cards, financial and non-financial services, electronic banking) with Banque Accord.
Auchan's company mission is to improve the purchasing power and the quality of life of the greatest number of its customers every day.
About Forbes Medi-Tech Inc.
Forbes Medi-Tech Inc. is a life sciences company dedicated to the research, development and commercialization of innovative products for the prevention and treatment of life-threatening disease. Our strategy and vision is to develop and market a portfolio of products for the benefit of all consumers, from the healthy person desiring consumer lifestyle products that can help reduce the risk of future disease, to medical patients needing therapeutic prescription products for the treatment of an established ailment. Additional information on Forbes Medi-Tech can be found at www.forbesmedi.com
# # #
NASDAQ and the Toronto Stock Exchange have not reviewed and do not accept responsibility for the adequacy or accuracy of the content of this News Release. Forbes Medi-Tech ("Forbes" or the "Company") has relied solely on Auchan for the information about Auchan provided in this News Release and the Company disclaims any liability with respect
to such information. This News Release contains forward-looking statements and information regarding Reducol(tm) and Forbes' strategy and vision, which statements can be identified by the use of forward-looking terminology such as "will", "strategy" and "vision".
The Company's actual results could differ materially from those anticipated in these forward-looking statements and information as a result of numerous factors, including the Company's need for funding in the near term, the availability and sufficiency of which is not assured; uncertainty whether the Company will realize is strategies and vision; intellectual property risks; manufacturing risks; product liability and insurance risks; the need for performance by Auchan and its customers; the effect of competition; changes in business strategy or development plans;and other risks and uncertainties, as contained in news releases and filings with Securities Regulatory Authorities in Canada and the U.S. at www.sedar.com and at www.sec.gov , any of which could cause actual results to vary materially from current results or the Company's anticipated future results. Forward-looking statements and information are based on the assumptions, beliefs, opinions and expectations of the Company's management at the time they are made, and the Company does not assume any obligation to update any statement should those assumptions, beliefs, opinions or expectations, or other circumstances change.